AAAAAA

   
Results: 1-11 |
Results: 11
PRECLINICAL EVALUATION OF THE GASTRIMMUNE IMMUNOGEN ALONE AND IN COMBINATION WITH 5-FLUOROURACIL LEUCOVORIN IN A RAT COLORECTAL-CANCER MODEL/
Authors: WATSON SA MICHAEL D JUSTIN TA GRIMES S MORRIS TM ROBINSON G CLARKE PA HARDCASTLE JD
Citation: Sa. Watson et al., PRECLINICAL EVALUATION OF THE GASTRIMMUNE IMMUNOGEN ALONE AND IN COMBINATION WITH 5-FLUOROURACIL LEUCOVORIN IN A RAT COLORECTAL-CANCER MODEL/, International journal of cancer, 75(6), 1998, pp. 873-877
THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE (MMP) INHIBITOR, MARIMASTAT, IN A GASTRIC-CANCER XENOGRAFT MODEL - RELATIONSHIP TO MMP MESSENGER-RNA LEVELS
Authors: TIERNEY GM COLLINS HM MORRIS TM SCHOLEFIELD JH WATSON SA
Citation: Gm. Tierney et al., THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE (MMP) INHIBITOR, MARIMASTAT, IN A GASTRIC-CANCER XENOGRAFT MODEL - RELATIONSHIP TO MMP MESSENGER-RNA LEVELS, British Journal of Surgery, 85(11), 1998, pp. 1562-1562
THE USE OF A MURINE MODEL OF FAMILIAL ADENOMATOUS POLYPOSIS TO STUDY THE VARIATION IN E-CADHERIN AND BETA-CATENIN EXPRESSION
Authors: CLARK DJ WATSON SA MORRIS TM SCHOLEFIELD JH
Citation: Dj. Clark et al., THE USE OF A MURINE MODEL OF FAMILIAL ADENOMATOUS POLYPOSIS TO STUDY THE VARIATION IN E-CADHERIN AND BETA-CATENIN EXPRESSION, British Journal of Cancer, 78, 1998, pp. 77-77
THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE INHIBITOR MARIMASTAT, IN A GASTRIC-CANCER XENOGRAFT MODEL - RELATIONSHIP TO CEA LEVELS
Authors: WATSON SA MORRIS TM COLLINS HM TIERNEY G BAWDEN LJ HAWKINS K BROWN PD BONE EA
Citation: Sa. Watson et al., THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE INHIBITOR MARIMASTAT, IN A GASTRIC-CANCER XENOGRAFT MODEL - RELATIONSHIP TO CEA LEVELS, British Journal of Cancer, 78, 1998, pp. 103-103
THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE INHIBITOR, MARIMASTAT IN A GASTRIC-CANCER XENOGRAFT MODEL - RELATIONSHIP TO MMP MESSENGER-RNA LEVELS
Authors: TIERNEY GM COLLINS HM MORRIS TM WATSON SA
Citation: Gm. Tierney et al., THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE INHIBITOR, MARIMASTAT IN A GASTRIC-CANCER XENOGRAFT MODEL - RELATIONSHIP TO MMP MESSENGER-RNA LEVELS, British Journal of Cancer, 78, 1998, pp. 104-104
EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESIRUDIN
Authors: LEFEVRE G DUVAL M GAURON S BROOKMAN LJ ROLAN PE MORRIS TM PIRAINO AJ MORGAN JM PALMISANO M CLOSE P
Citation: G. Lefevre et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESIRUDIN, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 50-59
GASTRIMMUNE RAISES ANTIBODIES THAT NEUTRALIZE AMIDATED AND GLYCINE-EXTENDED GASTRIN-17 AND INHIBIT THE GROWTH OF COLON-CANCER
Authors: WATSON SA MICHAELI D GRIMES S MORRIS TM ROBINSON G VARRO A JUSTIN TA HARDCASTLE JD
Citation: Sa. Watson et al., GASTRIMMUNE RAISES ANTIBODIES THAT NEUTRALIZE AMIDATED AND GLYCINE-EXTENDED GASTRIN-17 AND INHIBIT THE GROWTH OF COLON-CANCER, Cancer research, 56(4), 1996, pp. 880-885
THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE INHIBITOR, BATIMASTAT, IN A HUMAN COLORECTAL-CANCER ASCITES MODEL
Authors: WATSON SA MORRIS TM PARSONS SL STEELE RJC BROWN PD
Citation: Sa. Watson et al., THERAPEUTIC EFFECT OF THE MATRIX METALLOPROTEINASE INHIBITOR, BATIMASTAT, IN A HUMAN COLORECTAL-CANCER ASCITES MODEL, British Journal of Cancer, 74(9), 1996, pp. 1354-1358
ANTIGASTRIN ANTIBODIES RAISED BY GASTRIMMUNE INHIBIT GROWTH OF THE HUMAN COLORECTAL TUMOR AP5
Authors: WATSON SA MICHAELI D GRIMES S MORRIS TM CROSBEE D WILKINSON M ROBINSON G ROBERTSON JFR STEELE RJC HARDCASTLE JD
Citation: Sa. Watson et al., ANTIGASTRIN ANTIBODIES RAISED BY GASTRIMMUNE INHIBIT GROWTH OF THE HUMAN COLORECTAL TUMOR AP5, International journal of cancer, 61(2), 1995, pp. 233-240
INHIBITION OF ORGAN INVASION BY THE MATRIX METALLOPROTEINASE INHIBITOR BATIMASTAT (BB-94) IN 2 HUMAN COLON-CARCINOMA METASTASIS MODELS
Authors: WATSON SA MORRIS TM ROBINSON G CRIMMIN MJ BROWN PD HARDCASTLE JD
Citation: Sa. Watson et al., INHIBITION OF ORGAN INVASION BY THE MATRIX METALLOPROTEINASE INHIBITOR BATIMASTAT (BB-94) IN 2 HUMAN COLON-CARCINOMA METASTASIS MODELS, Cancer research, 55(16), 1995, pp. 3629-3633
A HEPATIC INVASIVE HUMAN COLORECTAL XENOGRAFT MODEL
Authors: WATSON SA MORRIS TM CROSBEE DM HARDCASTLE JD
Citation: Sa. Watson et al., A HEPATIC INVASIVE HUMAN COLORECTAL XENOGRAFT MODEL, European journal of cancer, 29A(12), 1993, pp. 1740-1745
Risultati: 1-11 |